**Core Concept**
Paraneoplastic syndromes refer to systemic disorders caused by cancer that are not due to direct local effects, such as invasion or metastasis. Hypercalcemia, or elevated calcium levels, is a common paraneoplastic syndrome associated with certain cancers.

**Why the Correct Answer is Right**
Hypercalcemia of malignancy is often caused by the production of parathyroid hormone-related protein (PTHrP) by cancer cells. Renal cell carcinoma (RCC) is one of the cancers most commonly associated with hypercalcemia due to the production of PTHrP, which stimulates osteoclast activity and leads to bone resorption and increased calcium levels. This mechanism is distinct from primary hyperparathyroidism, where PTH is overproduced.

**Why Each Wrong Option is Incorrect**
**Option B:** Carcinoma stomach is not typically associated with hypercalcemia as a paraneoplastic syndrome. Other gastrointestinal malignancies like squamous cell carcinoma of the esophagus or medullary thyroid cancer may cause hypercalcemia, but stomach cancer is not a common cause.
**Option C:** Small cell carcinoma lung is more commonly associated with paraneoplastic syndromes such as Eaton-Lambert syndrome (a neuromuscular disorder) or SIADH (syndrome of inappropriate antidiuretic hormone secretion), but not typically with hypercalcemia.
**Option D:** Hepatocellular carcinoma is not commonly associated with hypercalcemia as a paraneoplastic syndrome. While liver cancer can cause a variety of systemic symptoms, hypercalcemia is not typically one of them.

**Clinical Pearl / High-Yield Fact**
When evaluating a patient with hypercalcemia, it is essential to consider the possibility of a paraneoplastic syndrome, particularly in the context of a known or suspected malignancy. A thorough history and physical examination, combined with laboratory tests and imaging studies, can help identify the underlying cause of hypercalcemia.

**✓ Correct Answer: A. RCC. Renal cell carcinoma is a common cause of hypercalcemia due to the production of parathyroid hormone-related protein (PTHrP).**